Irwin C Jacobs

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 201(Granted Patents)

Location History:

Eureka, MO (US) (1988 - 2010)
Defiance, MO (US) (2018 - 2024)

Company Filing History:

Petrolite Corporation

patents

3 out of 3

Boulder Bioscience LLC

patents

4. 1 out of 2

Particle and Coating Technologies, Inc.

Years Active: 1988-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171745 - Compositions and methods for treating non-hemorrhagic closed head injury (2024-12-24),

2. 11980604 - Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane (2024-05-14),

3. 11529331 - Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane (2022-12-20),

4. 11337961 - Self-emulsifying formulations of DIM-related indoles (2022-05-24),

5. 10799479 - Self-emulsifying formulations of DIM-related indoles (2020-10-13),

6. 10441569 - Self-emulsifying formulations of DIM-related indoles (2019-10-15),

7. 9918965 - Self-emulsifying formulations of DIM-related indoles (2018-03-20),

8. 7713548 - Amorphous solid dispersions (2010-05-11),

9. 6544552 - Method of producing porous tablets with improved dissolution properties (2003-04-08),

10. 6416793 - Formulations and use of controlled-release indole alkaloids (2002-07-09),

11. 6086915 - Compositions and methods of adjusting steroid hormone metabolism through (2000-07-11),

12. 5902565 - Spray dried vaccine preparation comprising aluminium adsorbed immunogens (1999-05-11),

13. 5336433 - Bleaching agent (1994-08-09),

14. 5130473 - Dithiocarbamate compounds (1992-07-14),

15. 5112505 - Certain dithiocarbamates and method of use for reducing asphaltene (1992-05-12),

Title: Discovering the Innovations of Irwin C. Jacobs

Introduction

Irwin C. Jacobs, a notable inventor based in Defiance, Missouri, has made significant contributions to the field of medical treatment, particularly in the area of traumatic brain injuries. With 16 patents to his name, he has developed innovative methods and compositions aimed at improving patient outcomes in critical scenarios.

Latest Patents

Among his latest patents is a method for treating non-hemorrhagic closed head injury (NHCHI) using 3,3'-diindolylmethane or its analogs. This patent addresses various forms of Traumatic Brain Injuries (TBIs), including mild to severe concussions, blast injuries, cerebral contusions, and other related conditions. Additionally, he has developed methods for enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis, utilizing the same compound, 3,3'-diindolylmethane. These innovations reflect Jacobs' commitment to addressing complex medical challenges.

Career Highlights

Irwin C. Jacobs has had a vibrant career, working with notable companies such as Bioresponse, L.L.C. and Petrolite Corporation. His work at these organizations has allowed him to further develop his innovative ideas and contribute to significant advancements in the medical field.

Collaborations

Throughout his career, Jacobs has collaborated with talented individuals, including Michael A. Zeligs and Robert E. Sparks. These partnerships have facilitated the exchange of ideas and fostered an environment of creativity that is crucial for innovation.

Conclusion

Irwin C. Jacobs stands out as a remarkable inventor whose work in medical treatment is both impactful and inspiring. His numerous patents and collaborative efforts exemplify his dedication to advancing healthcare through innovation. As research continues to evolve, Jacobs' contributions will undoubtedly play a vital role in shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.